News

You are here:

Home
News

ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production

July 15, 2020

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a company dedicated to improving quality of life through research and leadership in bio-pharmaceuticals and cannabinoid-based formulations, announced today that it has reached a positive milestone in the development of COVID-19 vaccine components by achieving plant-based expression, isolation, and purification of a potential antigen for a SARS-CoV-2 vaccine…

Details

Bluma Wellness Announces Share for Debt Settlements and Grant of RSUs

July 15, 2020

TORONTO–(BUSINESS WIRE)–Bluma Wellness Inc. (the “Company”) (CSE: BWEL.U) announced that it has entered into shares for debt agreements with four arm’s-length consultants for advisory services rendered to the Company (collectively, the “Shares for Debt Agreements”). Pursuant to the terms and subject to the conditions of the Shares for Debt Agreements, the Company will issue an…

Details

ManifestSeven Receives Conditional Approval To Trade on Canadian Securities Exchange

July 15, 2020

LOS ANGELES & IRVINE, Calif.–(BUSINESS WIRE)–ManifestSeven (“M7” or “the Company”) today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (“CSE”). Subject to satisfying customary listing obligations, the Company’s common shares will commence trading on the CSE under the ticker symbol “MSVN”. “This is a…

Details

HERBL Implements Blue Yonder’s Luminate Platform to Create a Highly Efficient and Quality Supply Chain

July 15, 2020

SCOTTSDALE, Ariz. & SANTA BARBARA, Calif.–(BUSINESS WIRE)–Blue Yonder today announced that California’s largest cannabis distributor and supply chain solutions company, HERBL Solutions, is developing an end-to-end supply chain and fulfillment backbone with Blue Yonder’s Luminate™ Platform as its foundation. This digital fulfillment platform allows accurate inventory visibility, associated data transparency, and greater forecasting performance ensuring…

Details

Assessment of COVID-19's Effect on Medical Marijuana Market 2020-2024 | Production Of Medical Marijuana to Augment Growth | Technavio

July 15, 2020

LONDON–(BUSINESS WIRE)–Technavio has been monitoring the medical marijuana market and it is poised to grow by USD 22.33 bn during 2020-2024, progressing at a CAGR of over 24% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19…

Details

SierraConstellation Partners Continues National Expansion with Three Promotions and Senior Seattle Hire

July 16, 2020

LOS ANGELES–(BUSINESS WIRE)–SierraConstellation Partners, LLC (SCP), a national interim management and advisory firm to middle-market companies in transition, today announced that it has promoted three senior professionals and hired Nevin Shetty as a Managing Director in Seattle as the firm continues its growth and expansion across the United States. The three senior promotions are: Curt…

Details

Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2

July 16, 2020

DENVER–(BUSINESS WIRE)–Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery systems, today announced that on July 7, 2020, it was issued a patent (US10,702,495) by the United States Patent and Trademark Office (USPTO).. This patent…

Details

CBD Skincare Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Benefits of CBD in Skincare to Boost the Market Growth | Technavio

July 17, 2020

LONDON–(BUSINESS WIRE)–Technavio has been monitoring the CBD skincare market and it is poised to grow by USD 1.64 billion during 2020-2024, progressing at a CAGR of over 33% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19…

Details

Halo Announces Closing of Acquisition of Bophelo Bioscience and Appoints Louisa Mojela as Chairman

July 17, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has closed its previously announced acquisition (the “Acquisition”) of Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”). Concurrently with closing, Ms. Louisa Mojela was appointed as a director and Chairman of Halo’s board of directors (the…

Details

Terrace Global Announces $15 Million Financing

July 17, 2020

TORONTO–(BUSINESS WIRE)–Terrace Global Inc. (“Terrace Global” or the “Company”) (TSXV:TRCE) is pleased to announce that, subject to applicable regulatory approvals, the Company intends to complete a non-brokered private placement (the “Private Placement”) of subscription receipts (the “Subscription Receipts”). The Private Placement is expected to close on or about July 30, 2020. The Company intends to…

Details

Global Dairy Alternatives Market (2020 to 2025) – Changes in Lifestyles of Consumers Presents Opportunities – ResearchAndMarkets.com

July 20, 2020

DUBLIN–(BUSINESS WIRE)–The “Dairy Alternatives Market by Source (Soy, Almond, Coconut, Rice, Oats, Hemp), Application (Milk, Cheese, Yogurt, Ice Creams, Creamers), Distribution Channel (Supermarkets, Health Stores, Pharmacies), Formulation and Region – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The global dairy alternatives market was valued at USD 21.44 billion in 2019 and…

Details

Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds

July 20, 2020

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today it has completed the development of a biological cell-based in vitro assay which can identify clinically active cannabis derived compounds that bind to and activate…

Details